Journal
MINERVA CARDIOLOGY AND ANGIOLOGY
Volume 69, Issue 1, Pages 28-35Publisher
EDIZIONI MINERVA MEDICA
DOI: 10.23736/S2724-5683.20.05094-X
Keywords
Ankle brachial index; Peripheral arterial disease; Intermittent claudication; Autonomic nervous system
Categories
Ask authors/readers for more resources
The specific role of sympathetic neural control and dysregulation in lower extremities arterial disease (LEAD) is still limited. This study found that LEAD patients had lower heart rate variability compared to controls, and the autonomic dysfunction was more significant in clinically advanced stages of the disease.
BACKGROUND: The understanding of the specific role of sympathetic neural control and dysregulation in lower extremities arterial disease (LEAD) is still very limited. Aim of our study was to investigate the autonomic profile in LEAD patients and to evaluate if the eventual autonomic alterations were more severe in patients with advanced disease. METHODS: We enrolled all consecutive outpatients with LEAD referred to our Departments between July 2012 and September 2014. They were compared to a group of matched outpatients without LEAD. All patients underwent Holter ECG monitoring. Time-domain analysis of heart rate variability (HRV) was evaluated. RESULTS: Compared to controls, patients with LEAD had a lower SDNN (P=0.007) and SDANN (P=0.003). Patients with clinically advanced LEAD had a lower SDNN (P=0.006) and SDANN (P=0.004) compared to LEAD patients with less severe disease and to those without disease. CONCLUSIONS: LEAD patients had a reduced SDNN and SDANN than patients without LEAD. Autonomic dysfunction was more significant in clinically advanced stages of disease. This association did not relate to ABI value but to clinical stage of disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available